Cargando…
Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice
Peptide-based vaccines are attractive approaches for cancer immunotherapy; but the success of these vaccines in clinical trials have been limited. Our goal is to improve immune responses and anti-tumor effects against a synthetic, multi-epitope, long peptide from rat Her2/neu (rHer2/neu) using the h...
Autores principales: | Ghaffari-Nazari, Haniyeh, Tavakkol-Afshari, Jalil, Jaafari, Mahmoud Reza, Tahaghoghi-Hajghorbani, Sahar, Masoumi, Elham, Jalali, Seyed Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640540/ https://www.ncbi.nlm.nih.gov/pubmed/26556756 http://dx.doi.org/10.1371/journal.pone.0142563 |
Ejemplares similares
-
Enhanced immune response induced by P5 HER2/neu‐derived peptide‐pulsed dendritic cells as a preventive cancer vaccine
por: Gholizadeh, Zahra, et al.
Publicado: (2017) -
Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments
por: Rostami, Elham, et al.
Publicado: (2022) -
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023) -
The role of dysregulated immune responses in COVID-19 pathogenesis
por: Tahaghoghi-Hajghorbani, S, et al.
Publicado: (2020) -
The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)